Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.

Autor: Kochneva ОL; City Clinical Hospital No. 52, Moscow, Russia., Kislova M; Botkin Hospital, Moscow, Russia., Zhelnova EI; City Clinical Hospital No. 52, Moscow, Russia., Petrenko AA; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation.; Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, Moscow, Russia., Baryakh EA; City Clinical Hospital No. 52, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Yatskov KV; City Clinical Hospital No. 52, Moscow, Russia., Dmitrieva EA; Botkin Hospital, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Misurina EN; City Clinical Hospital No. 52, Moscow, Russia., Nikitin KE; Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, Moscow, Russia., Vasilieva EJ; Davidovsky City Clinical Hospital, Moscow, Russia., Samsonova IV; City Clinical Hospital No. 52, Moscow, Russia., Ptushkin VV; Botkin Hospital, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Baranova A; School of Systems Biology, George Mason University, Fairfax, VA, USA.; Research Center for Medical Genetics, Moscow, Russia., Nikitin EA; Botkin Hospital, Moscow, Russia.; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2022 Jul; Vol. 63 (7), pp. 1607-1616. Date of Electronic Publication: 2022 Feb 13.

N-Terminal Fragment of Brain-Type Natriuretic Peptide (NT-proBNP) as a Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure.

Autor: Semochkin SV; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia. semochkin_sv@rsmu.ru.; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia. semochkin_sv@rsmu.ru., Misyurina EN; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Zhelnova EI; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Yurova EV; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia., Gagloeva DE; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Aref'eva NA; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Ushakova AI; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Kotenko ON; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Tolstykh TN; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Sinyavkin DO; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Baryakh EA; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia.; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia., Yatskov KV; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Samsonova IV; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia., Lysenko MA; Municipal Clinical Hospital No. 52, Moscow Healthcare Department, Ministry of Health of the Russian Federation, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2019 Jun; Vol. 167 (2), pp. 267-271. Date of Electronic Publication: 2019 Jun 24.

[Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].

Autor: Baryakh EA; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Tyurina NG; P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russia., Vorobyev VI; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Gemdzhyan EG; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Mangasarova YK; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Klyasova GA; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Kovrigina AM; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Obukhova TN; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Zvonkov EE; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Vernyuk MA; P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russia., Chervontseva AM; P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow, Russia., Polyakov YY; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Misyurina АЕ; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Valiev TT; Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Zherebtsova VA; Central Clinical Hospital with Polyclinic, Department for Presidential Affairs of the Russian Federation, Moscow, Russia., Magomedova AU; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Galstyan GM; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Yatskov KV; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Nesterova ES; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Vorobyev AI; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia., Kravchenko SK; Hematology Research Center, Ministry of Health of Russia, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (7), pp. 4-14.